Abstract
From our previous study, the aqueous soluble polysaccharides isolated from cold aqueous extract of Ulva fascinate was prepared and represented as the most of its bioactive constituents. The polysaccharides were formulated as autosomal nanoparticles for use as anti-hepatocirrhosis drugs. The formulations were characterized by their encapsulation efficiency, particle size, zeta potential and in vitro release. The selected formulation was subjected to a preclinical study. Serum biomarkers enzymes (aspartate and alanine aminotransferases and alkaline phosphatase) were proved the efficacy of the polysaccharides loaded cub some similar to the reference drug; silymarin in addition to its safety on liver. The histopathological examination was conducted to document the biochemical results.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Open Journal of Pharmaceutical Science and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
